OA
ATE

Operose Advisors’s Advantest Corp ATE Stock Holding History

Operose Advisors’s Portfolio ATE Stock Details ATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-287
Closed -$32.1K – 759
2023
Q3 		$32.1K Buy
+287
New +$32.1K 0.01% 387

Other funds holding ATE

ACM
Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return

Operose Advisors's ATE Position: Q4 2023 in Review

Operose Advisors sold out of Advantest Corp (ATE) in Q4 2023, closing a stake of 287 shares — an estimated $32.1K sold.

Operose Advisors first reported a position in ATE in Q3 2023 and held it in 1 quarter. The position peaked at $32.1K in Q3 2023. 7 funds tracked by Wall St. Rank hold ATE as of Q4 2023.

  • Operose Advisors reported no remaining Advantest Corp position as of Q4 2023 after selling out during the quarter.
  • Operose Advisors sold 287 Advantest Corp shares in Q4 2023, an estimated $32.1K.
  • Operose Advisors first reported a position in Advantest Corp in Q3 2023 and held it in 1 quarter.
  • Operose Advisors's Advantest Corp position peaked at $32.1K in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Advantest Corp as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.